Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,623 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Cortellini A, D'Alessio A, Cleary S, Buti S, Bersanelli M, Bordi P, Tonini G, Vincenzi B, Tucci M, Russo A, Pantano F, Russano M, Stucci LS, Sergi MC, Falconi M, Zarzana MA, Santini D, Spagnolo F, Tanda ET, Rastelli F, Giorgi FC, Pergolesi F, Giusti R, Filetti M, Lo Bianco F, Marchetti P, Botticelli A, Gelibter A, Siringo M, Ferrari M, Marconcini R, Vitale MG, Nicolardi L, Chiari R, Ghidini M, Nigro O, Grossi F, De Tursi M, Di Marino P, Queirolo P, Bracarda S, Macrini S, Inno A, Zoratto F, Veltri E, Spoto C, Vitale MG, Cannita K, Gennari A, Morganstein DL, Mallardo D, Nibid L, Sabarese G, Brunetti L, Perrone G, Ascierto PA, Ficorella C, Pinato DJ. Cortellini A, et al. Among authors: ferrari m. Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. doi: 10.1158/1078-0432.CCR-22-3116. Clin Cancer Res. 2023. PMID: 37125965
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System.
Lechner M, Takahashi Y, Turri-Zanoni M, Ferrari M, Liu J, Counsell N, Mattavelli D, Rampinelli V, Vermi W, Lombardi D, Saade R, Park KW, Schartinger VH, Franchi A, Facco C, Sessa F, Battocchio S, Fenton TR, Vaz FM, O'Flynn P, Howard D, Stimpson P, Wang S, Hannan SA, Unadkat S, Hughes J, Dwivedi R, Forde CT, Randhawa P, Gane S, Joseph J, Andrews PJ, Dave M, Fleming JC, Thomson D, Zhu T, Teschendorff A, Royle G, Steele C, Jimenez JE, Laco J, Wang EW, Snyderman C, Lacy PD, Woods R, O'Neill JP, Saraswathula A, Kaur RP, Zhao T, Ramanathan M Jr, Gallia GL, London NR Jr, Le QT, West RB, Patel ZM, Nayak JV, Hwang PH, Hermsen M, Llorente J, Facchetti F, Nicolai P, Bossi P, Castelnuovo P, Jay A, Carnell D, Forster MD, Bell DM, Lund VJ, Hanna EY. Lechner M, et al. Among authors: ferrari m. J Neurol Surg B Skull Base. 2022 Jul 10;84(4):307-319. doi: 10.1055/s-0042-1750178. eCollection 2023 Aug. J Neurol Surg B Skull Base. 2022. PMID: 37405239 Free PMC article.
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours.
Bossi P, Orlandi E, Resteghini C, Vischioni B, Nicolai P, Castelnuovo P, Gambazza S, Locati LD, Turri-Zanoni M, Ferrari M, Facchinetti N, Iacovelli NA, Calareso G, Quattrone P, Cavallo A, Tuzi A, Licitra L. Bossi P, et al. Among authors: ferrari m. Eur J Cancer. 2023 Jul;187:134-143. doi: 10.1016/j.ejca.2023.03.034. Epub 2023 Apr 7. Eur J Cancer. 2023. PMID: 37163806 Clinical Trial.
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram.
Rampinelli V, Ferrari M, Mattavelli D, Bonomo P, Lambertoni A, Turri-Zanoni M, D'Angelo E, Alterio D, Cianchetti M, Vischioni B, Rosati R, Tomasoni M, Alparone M, Taboni S, Tomasini D, Maddalo M, Bastia MBDM, Iacovelli NA, Dionisi F, Bignami M, Battaglia P, Bossi P, Deganello A, Piazza C, Schreiber A, Nicolai P, Castelnuovo P, Orlandi E. Rampinelli V, et al. Among authors: ferrari m. Front Oncol. 2023 May 16;13:1157584. doi: 10.3389/fonc.2023.1157584. eCollection 2023. Front Oncol. 2023. PMID: 37260976 Free PMC article.
Validation of modular endoscopic medial maxillectomies for inverted papilloma of the maxillary sinus.
Vinciguerra A, Mattavelli D, Turri-Zanoni M, Ferrari M, Schreiber A, Rampinelli V, Dohin I, Valentini M, Pontillo V, Gaudioso P, Karligkiotis A, Atallah S, Chatelet F, Saccardo T, Piazza C, Verillaud B, Nicolai P, Castelnuovo P, Herman P. Vinciguerra A, et al. Among authors: ferrari m. Rhinology. 2023 Aug 1;61(4):368-375. doi: 10.4193/Rhin23.035. Rhinology. 2023. PMID: 37515817
Transnasal endoscopic surgery in selected nasal-ethmoidal cancer with suspected brain invasion: Indications, technique, and outcomes.
Mattavelli D, Ferrari M, Bolzoni Villaret A, Schreiber A, Rampinelli V, Turri-Zanoni M, Lancini D, Taglietti V, Accorona R, Doglietto F, Battaglia P, Castelnuovo P, Nicolai P. Mattavelli D, et al. Among authors: ferrari m. Head Neck. 2019 Jun;41(6):1854-1862. doi: 10.1002/hed.25621. Epub 2019 Jan 12. Head Neck. 2019. PMID: 30636181
Prognostic Value of Anteroposterior Extension in Oral Tongue and Floor Squamous Cell Carcinoma.
Contro G, Sordi A, Taboni S, Citterio M, Ruaro A, De Lucia G, Pinacoli A, Carobbio ALC, Montalto N, Ramacciotti G, Grammatica A, Marioni G, Zanoletti E, Maroldi R, Piazza C, Mattavelli D, Nicolai P, Ferrari M. Contro G, et al. Among authors: ferrari m. JAMA Otolaryngol Head Neck Surg. 2024 Feb 1;150(2):142-150. doi: 10.1001/jamaoto.2023.3809. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38153706
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Lechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M, Kaur RP, Zhao T, Ramanathan M Jr, Schartinger VH, Emanuel O, Helman S, Varghese J, Dudas J, Riechelmann H, Sprung S, Haybaeck J, Howard D, Engel NW, Stewart S, Brooks L, Pickles JC, Jacques TS, Fenton TR, Williams L, Vaz FM, O'Flynn P, Stimpson P, Wang S, Hannan SA, Unadkat S, Hughes J, Dwivedi R, Forde CT, Randhawa P, Gane S, Joseph J, Andrews PJ, Royle G, Franchi A, Maragliano R, Battocchio S, Bewicke-Copley H, Pipinikas C, Webster A, Thirlwell C, Ho D, Teschendorff A, Zhu T, Steele CD, Pillay N, Vanhaesebroeck B, Mohyeldin A, Fernandez-Miranda J, Park KW, Le QT, West RB, Saade R, Manes RP, Omay SB, Vining EM, Judson BL, Yarbrough WG, Sansovini M, Silvia N, Grassi I, Bongiovanni A, Capper D, Schüller U, Thavaraj S, Sandison A, Surda P, Hopkins C, Ferrari M, Mattavelli D, Rampinelli V, Facchetti F, Nicolai P, Bossi P, Henriquez OA, Magliocca K, Solares CA, Wise SK, Llorente JL, Patel ZM, Nayak JV, Hwang PH, Lacy PD, Woods R, O'Neill JP, Jay A, Carnell D, Forster MD, Ishii M, London NR Jr, Bell DM, Gallia GL, Castelnuovo P, Severi S, Lund VJ, Hanna EY. Lechner M, et al. Among authors: ferrari m. Eur J Cancer. 2022 Feb;162:221-236. doi: 10.1016/j.ejca.2021.09.046. Epub 2021 Dec 31. Eur J Cancer. 2022. PMID: 34980502 Free PMC article.
4,623 results